Detalle Publicación

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022

Autores: Ducreux, M. (Autor de correspondencia); Abou-Alfa, G. K.; Bekaii-Saab, T.; Berlin, J.; Cervantes, A.; de Baere, T.; Eng, C.; Galle, P.; Gill, S.; Gruenberger, T.; Haustermans, K.; Lamarca, A.; Laurent-Puig, P.; Llovet, J. M.; Lordick, F.; Macarulla, T.; Mukherji, D.; Muro, K.; Obermannova, R.; O'Connor, J. M.; O'Reilly, E. M.; Osterlund, P.; Philip, P.; Prager, G.; Ruiz-Garcia, E.; Sangro Gómez-Acebo, Bruno Carlos; Seufferlein, T.; Tabernero, J.; Verslype, C. ; Wasan, H. ; Van Cutsem, E.
Título de la revista: ESMO OPEN
ISSN: 2059-7029
Volumen: 8
Número: 3
Páginas: 101567
Fecha de publicación: 2023
Resumen:
This article summarises expert discussion on the management of patients with hepatocellular carcinoma (HCC), which took place during the 24th World Gastrointestinal Cancer Congress (WGICC) in Barcelona, July 2022. A multidisciplinary approach is mandatory to ensure an optimal diagnosis and staging of HCC, planning of curative and therapeutic options, including surgical, embolisation, ablative strategies, or systemic therapy. Furthermore, in many patients with HCC, underlying liver cirrhosis represents a challenge and influences the therapeutic options.
Impacto: